| Literature DB >> 26946324 |
Cristina Tintori1, Angela Corona2, Francesca Esposito2, Annalaura Brai1, Nicole Grandi2, Elisa Rita Ceresola3,4, Massimo Clementi3, Filippo Canducci3,4, Enzo Tramontano5, Maurizio Botta6.
Abstract
Because HIV-1 reverse transcriptase is an enzyme whose catalytic activity depends on its heterodimeric structure, this system could be a target for inhibitors that perturb the interactions between the protein subunits, p51 and p66. We previously demonstrated that the small molecule MAS0 reduced the association of the two RT subunits and simultaneously inhibited both the polymerase and ribonuclease H activities. In this study, some analogues of MAS0 were rationally selected by docking studies and evaluated in vitro for their ability to disrupt dimeric assembly. Two inhibitors were identified with improved activity compared to MAS0. This study lays the basis for the rational design of more potent inhibitors of RT dimerization.Entities:
Keywords: HIV-1 reverse transcriptase; dimerization inhibitors; protein-protein interaction; virtual screening; viruses
Mesh:
Substances:
Year: 2016 PMID: 26946324 DOI: 10.1002/cbic.201500668
Source DB: PubMed Journal: Chembiochem ISSN: 1439-4227 Impact factor: 3.164